ATE481981T1 - Behandlung von infektionen des verdauungstrakts mit enzymen - Google Patents

Behandlung von infektionen des verdauungstrakts mit enzymen

Info

Publication number
ATE481981T1
ATE481981T1 AT00989240T AT00989240T ATE481981T1 AT E481981 T1 ATE481981 T1 AT E481981T1 AT 00989240 T AT00989240 T AT 00989240T AT 00989240 T AT00989240 T AT 00989240T AT E481981 T1 ATE481981 T1 AT E481981T1
Authority
AT
Austria
Prior art keywords
enzymes
treatment
digestive tract
tract infections
infections
Prior art date
Application number
AT00989240T
Other languages
German (de)
English (en)
Inventor
David Anderson
Lin Liu
Humg-Yu Hsiao
Douglas Fodge
Original Assignee
Chemgen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22617824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE481981(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemgen Corp filed Critical Chemgen Corp
Application granted granted Critical
Publication of ATE481981T1 publication Critical patent/ATE481981T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04011—Phosphoinositide phospholipase C (3.1.4.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00989240T 1999-12-10 2000-12-08 Behandlung von infektionen des verdauungstrakts mit enzymen ATE481981T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16993599P 1999-12-10 1999-12-10
PCT/US2000/033466 WO2001041785A2 (en) 1999-12-10 2000-12-08 Enzyme treatment for infection

Publications (1)

Publication Number Publication Date
ATE481981T1 true ATE481981T1 (de) 2010-10-15

Family

ID=22617824

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00989240T ATE481981T1 (de) 1999-12-10 2000-12-08 Behandlung von infektionen des verdauungstrakts mit enzymen

Country Status (31)

Country Link
US (2) US6780628B2 (enEXAMPLES)
EP (1) EP1239872B1 (enEXAMPLES)
JP (1) JP4871473B2 (enEXAMPLES)
KR (1) KR100639746B1 (enEXAMPLES)
CN (3) CN101327320A (enEXAMPLES)
AR (2) AR026764A1 (enEXAMPLES)
AT (1) ATE481981T1 (enEXAMPLES)
AU (1) AU782831B2 (enEXAMPLES)
BR (1) BRPI0016231B8 (enEXAMPLES)
CA (1) CA2394856C (enEXAMPLES)
CL (1) CL2008000057A1 (enEXAMPLES)
CO (1) CO5280226A1 (enEXAMPLES)
CR (1) CR6674A (enEXAMPLES)
CZ (1) CZ304925B6 (enEXAMPLES)
DE (1) DE60045010D1 (enEXAMPLES)
DK (1) DK1239872T3 (enEXAMPLES)
ES (1) ES2353371T3 (enEXAMPLES)
HU (1) HU230301B1 (enEXAMPLES)
IL (2) IL150048A0 (enEXAMPLES)
IN (1) IN247731B (enEXAMPLES)
MX (1) MX264033B (enEXAMPLES)
MY (1) MY124714A (enEXAMPLES)
NZ (1) NZ519404A (enEXAMPLES)
PH (1) PH12000003381B1 (enEXAMPLES)
PL (1) PL203054B1 (enEXAMPLES)
PT (1) PT1239872E (enEXAMPLES)
RU (1) RU2272419C2 (enEXAMPLES)
SK (1) SK287956B6 (enEXAMPLES)
TW (1) TWI255189B (enEXAMPLES)
UA (1) UA78486C2 (enEXAMPLES)
WO (1) WO2001041785A2 (enEXAMPLES)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
EP1812550A2 (en) * 2004-10-20 2007-08-01 Iogenetics, Llc Biocides
US8916151B2 (en) 2005-04-25 2014-12-23 Cls Therapeutics Limited Method for treating a reduction of fertility
DK1973561T3 (da) 2005-12-15 2011-05-23 Chemgen Corp Enzymer til reducering af immunologisk stress
CA2636292C (en) * 2006-01-23 2011-04-19 Hill's Pet Nutrition, Inc. Methods for reducing food intake and controlling the weight of animals
RU2319481C1 (ru) * 2006-10-20 2008-03-20 Илья Николаевич Медведев Способ коррекции уровня оксида азота в крови поросят с острым катаральным энтеритом
KR20090087095A (ko) 2006-11-28 2009-08-14 드미트리 드미트리에비치 겐킨 조직의 세포외공간에서 증가된 데옥시리보핵산 함량과 관련된 인간 질병을 치료하는 방법 및 이 방법을 수행하기 위한 약학 제제
ES2550685T3 (es) * 2007-06-08 2015-11-11 Australian Poultry Crc Pty Ltd Toxina clostridial NetB
RU2440369C2 (ru) * 2007-08-03 2012-01-20 Бёрингер Ингельхайм Ветмедика Гмбх ГЕНЫ И БЕЛКИ Brachyspira hyodysenteriae И ИХ ПРИМЕНЕНИЕ
RU2495098C2 (ru) * 2007-12-20 2013-10-10 ДАНИСКО ЮЖс ИНК. Способ ферментативного удаления биопленки, композиция и набор
DK2254591T3 (da) * 2008-02-08 2017-11-06 Prothera Inc Inhibering eller behandling af gastrointestinal biofilm
RU2380901C1 (ru) * 2008-08-13 2010-02-10 Государственное научное учреждение Ставропольский научно-исследовательский институт животноводства и кормопроизводства Российской академии сельскохозяйственных наук Способ повышения однородности стада, живой массы, конверсии корма при выращивании цыплят
NZ626946A (en) 2012-02-16 2015-11-27 Lilly Co Eli Methods and compositions for reducing the environmental impact of animal waste
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
TWI656872B (zh) 2014-11-13 2019-04-21 美商益農美國公司 甲基鹽黴素於豬飼料中之抗病毒效果
WO2016190780A1 (en) 2015-05-22 2016-12-01 Dmitry Dmitrievich Genkin Extracellular dna as a therapeutic target in neurodegeneration
CN106119221A (zh) * 2016-06-28 2016-11-16 浙江省农业科学院 磷脂酰肌醇特异性磷脂酶c基因、载体、工程菌及应用
CN106318925B (zh) * 2016-08-19 2021-04-02 浙江省农业科学院 利用枯草芽孢杆菌高效表达pi-plc基因的方法
CN106615691B (zh) * 2016-10-11 2019-07-02 上海国龙生物技术集团有限公司 一种抗感染酶复合剂及其在饲料中的应用
US10501730B2 (en) * 2017-05-30 2019-12-10 Ab Enzymes Oy Mannanase variants
EP3740581A4 (en) 2018-01-16 2021-10-27 CLS Therapeutics Limited TREATMENT OF DISEASES BY HEPATIC EXPRESSION OF AN ENZYME WHICH HAS DEOXYRIBONUCLEASE ACTIVITY (DNASE)
EP3759495A1 (en) * 2018-03-02 2021-01-06 Evonik Operations GmbH In vitro method for detecting intestinal barrier failure in animals
RU2720471C1 (ru) * 2019-03-21 2020-04-30 Федеральное Государственное бюджетное научное учреждение "Федеральный научный центр биологических систем и агротехнологий российской академии наук" Кормовая добавка для цыплят-бройлеров

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS5534039A (en) 1978-08-30 1980-03-10 Hiroo Ikezawa Preparation of phsophatidylinositol phospholipase c from bacillus thuringiensis
DE229810T1 (de) 1985-07-09 1987-11-05 Quadrant Bioresources Ltd., Soulbury, Leighton Buzzard, Bedfordshire Beschuetzung von proteinen und aehnlichem.
US5049379A (en) 1987-07-27 1991-09-17 Wisconsin Alumni Research Foundation Fungicidal toxin and method and inoculum for controlling root rot and damping off
US4877738A (en) 1986-07-25 1989-10-31 Wisconsin Alumni Research Foundation Biological control of damping off and root rot and inoculum preparation therefor
JPH0338530A (ja) * 1989-07-03 1991-02-19 Ajinomoto Co Inc 抗真菌剤
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
ES2114889T3 (es) 1990-05-29 1998-06-16 Chemgen Corp Suplemento de semicelulasa que mejora el rendimiento energetico de alimentos que contienen hemicelulosa y producto alimentario para animales.
EP0477739A3 (en) * 1990-09-27 1992-12-09 F. Hoffmann-La Roche Ag Glycosyl-phosphatidylinositol-specific phospholipase d
JPH06511237A (ja) * 1991-07-24 1994-12-15 コ、トーマス　サイ　イーング 治療用組成物およびその製造方法
JPH07184642A (ja) * 1993-12-27 1995-07-25 Toagosei Co Ltd ホスホリパーゼｃの生産方法
EP0743017B1 (en) * 1995-05-15 2004-09-29 DSM IP Assets B.V. Application of phospholipases in animal feed
NL1003096C2 (nl) * 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
JPH08332032A (ja) * 1995-06-12 1996-12-17 Showa Denko Kk 動物経口物用酵素剤及びその用途
JP3914585B2 (ja) * 1995-10-19 2007-05-16 イーエヌ大塚製薬株式会社 マクロファージ一酸化窒素産生亢進剤
US6162473A (en) * 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
CN1092495C (zh) * 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
JPH1045581A (ja) * 1996-07-29 1998-02-17 Hideyo Yamaguchi 好中球機能低下抑制剤又は感染防御剤
CN1235636A (zh) * 1996-10-31 1999-11-17 诺沃挪第克公司 新型磷脂酶,及其生产和应用
EP1121021A1 (en) 1998-10-15 2001-08-08 Dsm N.V. Antimicrobial enzymes in animal feed
UA78486C2 (uk) 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
US20020116029A1 (en) * 2001-02-20 2002-08-22 Victor Miller MRI-compatible pacemaker with power carrying photonic catheter and isolated pulse generating electronics providing VOO functionality

Also Published As

Publication number Publication date
AR089799A2 (es) 2014-09-17
US7723091B2 (en) 2010-05-25
MXPA02005735A (es) 2003-10-14
CA2394856A1 (en) 2001-06-14
JP4871473B2 (ja) 2012-02-08
AR026764A1 (es) 2003-02-26
MY124714A (en) 2006-06-30
SK8262002A3 (en) 2002-12-03
CR6674A (es) 2007-02-22
SK287956B6 (sk) 2012-07-03
CN102172262A (zh) 2011-09-07
UA78486C2 (uk) 2007-04-10
US20020048576A1 (en) 2002-04-25
PH12000003381B1 (en) 2010-04-16
CZ20022007A3 (cs) 2002-11-13
WO2001041785A2 (en) 2001-06-14
IN247731B (enEXAMPLES) 2011-05-13
AU782831B2 (en) 2005-09-01
HUP0203402A2 (hu) 2003-02-28
PL356175A1 (en) 2004-06-14
RU2272419C2 (ru) 2006-03-27
CA2394856C (en) 2011-05-10
CN1433319A (zh) 2003-07-30
PL203054B1 (pl) 2009-08-31
HUP0203402A3 (en) 2004-12-28
BRPI0016231B1 (pt) 2016-10-04
TWI255189B (en) 2006-05-21
CL2008000057A1 (es) 2008-03-14
EP1239872B1 (en) 2010-09-22
HU230301B1 (hu) 2015-12-28
CN102172262B (zh) 2014-03-05
US20040223961A1 (en) 2004-11-11
DE60045010D1 (de) 2010-11-04
US6780628B2 (en) 2004-08-24
AU2577601A (en) 2001-06-18
IL150048A0 (en) 2002-12-01
IL150048A (en) 2016-09-29
ES2353371T3 (es) 2011-03-01
MX264033B (es) 2009-01-22
KR20020069204A (ko) 2002-08-29
BR0016231A (pt) 2003-06-24
JP2003520207A (ja) 2003-07-02
CO5280226A1 (es) 2003-05-30
BRPI0016231B8 (pt) 2021-05-25
WO2001041785A3 (en) 2002-01-24
PT1239872E (pt) 2010-12-03
EP1239872A2 (en) 2002-09-18
KR100639746B1 (ko) 2006-10-30
DK1239872T3 (da) 2010-10-25
IN2002DE00585A (enEXAMPLES) 2009-03-20
CN101327320A (zh) 2008-12-24
CZ304925B6 (cs) 2015-01-28
NZ519404A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
ATE481981T1 (de) Behandlung von infektionen des verdauungstrakts mit enzymen
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
EP1017402A4 (en) INTESTINAL ACID SYNDROME THERAPY
DE60001421D1 (de) Behandlung von abgas
EA200300025A1 (ru) Способ лечения патологического синдрома и лекарственное средство
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE325614T1 (de) Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
DE60031974D1 (de) Abgeschwaechte mikroorganismen fuer die behandlung von infektionen
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
EP1117431A4 (en) TREATMENT OF ACIDOSIS
EP1239851A4 (en) TREATMENT OF HYPERPROLIFERATIVE DISORDERS
DE60021065D1 (de) Virus behandlung
EP1315503A4 (en) TREATMENT AGAINST URINARY DYSFUNCTION
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus
DE60103685D1 (de) Behandlung von Poriomania
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
EP1233967A4 (en) PYRIDINONES FOR THE TREATMENT AND PREVENTION OF BACTERIAL INFECTIONS
NO20022949D0 (no) Attenuerte mikroorganismer for behandling av infeksjon
DE60125035D1 (de) Behandlung von plasmid-haltigen lösungen
ATE267598T1 (de) Virus behandlung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1239872

Country of ref document: EP